Joshua Horn

(Part three of a three-part series) See previous stories: Fox Rothschild Cannabis Attorney Analyzes Psychedelics Regs And Changing Public Perceptions Psychedelics Education, Rescheduling & Decriminalization As Seen By Fox Rothschild's Cannabis Partner Part one of our series discussed...

(Part two of a three-part series) Previous story in the series: Fox Rothschild Cannabis Attorney Analyzes Psychedelics Regs And Changing Public Perceptions Part one discussed the growth and specificity of psilocybin therapy as it becomes legalized in states, the potential parallels with...

(Part one of a three-part series) Psychedelics as a field has seen a great deal of progress over the past several months, ranging from positive results in clinical trials such as MAPS’ MDMA trial for PTSD and COMPASS (NASDAQ: CMPS)’ psilocybin trial for Treatment-...